Ming Fai International Holdings Limited Overview
Ming Fai International Holdings is a Hong Kong-headquartered, Cayman-incorporated, family-controlled manufacturer and distributor of guest amenities and operating supplies for the global hospitality and airline industries, with a smaller health-care and hygienic products contract-manufacturing arm serving North American customers. Founded by Chairman Ching Chi Fai, it describes itself as the first hotel-amenities supplier from the PRC region to list in Hong Kong (2007). The group generated HK$2,238.7 million of revenue in FY2025, 84% of it from hospitality supplies, sold across mainland China, Hong Kong, North America, Europe, Australia and other Asia-Pacific markets. Manufacturing is anchored in Shenzhen and a 130,240 m² Cambodian plant that is increasingly central to tariff-driven supply-chain repositioning. The company runs a net-cash balance sheet, pays out roughly half of earnings, and trades at a deep discount to book value — but faces sustained gross-margin compression from manufacturing costs, competition and trade-policy volatility.
Company's own description (paraphrased from AR25 and IR26)
AR25's Directors' Report states that the Company is an investment holding company whose subsidiaries are principally engaged in three activities: (i) manufacturing and trading of hospitality supplies products ("Hospitality Supplies Business"); (ii) trading of operating supplies and equipment ("OS&E Business"); and (iii) manufacturing and trading of health care and hygienic products ("Health Care and Hygienic Products Business"). The group's stated corporate aim (AR25, IR26) is to become a leading international corporate brand specialising in hospitality supplies and personal care products, create value for stakeholders, and support ecological sustainability.
The company's current web positioning emphasises four decades of experience, serving more than 100 million hotel and airline guests a year in-room and in-flight, and a product range spanning hotel supplies and equipment, airline and hospitality amenities, and personal-care products (WEB, accessed Oct 2026).
Independent characterisation
| Revenue type | Description | Approximate weight (FY2025) | Basis |
|---|---|---|---|
| Manufactured products | Hotel/airline amenities (wet and dry), health-care & hygienic products | ~90% (Hospitality Supplies 84.0% + Health Care 5.8%) | AR25 segment split; note Hospitality Supplies also includes some traded goods |
| Traded products | OS&E (linens, ceramics, kitchenware, lobby/cleaning supplies, outdoor furniture) | ~10% (OS&E 10.2%) | AR25 |
| Services / subscription | None reported | 0% | AR25 |
| Licensing | Group acts as licensee/distributor of third-party brands (e.g., Lanvin hotel amenities rights in Asia Pacific from 2012); no licensing income reported | — | WEB |
| Property rental | Rental income from investment properties | HK$1.9M in H1 2026 (in other income) | IR26 |
Ming Fai is best understood as a B2B private-label and licensed-brand contract manufacturer of consumable guest amenities, overlaid with a trading/distribution business in hotel operating supplies. The economics are those of a mid-margin light-manufacturing exporter: gross margins in the low-to-mid 20s, operating margins of 5–8% in normal years, heavy labour content (employee benefit expense of HK$549.1 million in FY2025, equal to ~24.5% of revenue — AR25), and working capital intensity driven by long receivable cycles (credit terms of 15–120 days; ~105 days DSO in FY2025, derived).
Revenue model mix (as inferred from segment disclosures; the company does not report a product/service/licensing split):
Value-chain position: Ming Fai is vertically integrated from mould development, extrusion blow-moulding of bottles, paper printing and soft-goods sewing through to filling, packaging and logistics (WEB). In OS&E it is a sourcing and project-supply intermediary for new-build and refurbishing hotels, principally in mainland China.
Customer types (AR25 risk section): direct sales to hotels and airline operators, sales to distributors, and sales to other end-users. Customer concentration is moderate: the five largest customers accounted for less than 30% of FY2025 revenue, and the five largest suppliers for less than 30% of purchases (AR25).
End-markets served:
-
International hotel chains and independent hotels (in-room amenities, OS&E for openings)
-
Airlines (in-flight amenity kits and toiletries)
-
Cruise lines (the operating subsidiary appears in cruise-industry supplier directories)
-
North American health-care/hygiene brand owners (contract manufacturing; 95.5% of the Health Care segment's FY2025 revenue came from North America — AR25)
Strategy
Stated strategic themes (paraphrased from AR25 Outlook and IR26 Outlook)
AR25 and IR26 organise strategy around five recurring themes:
-
Navigating global tourism under uncertainty. Maintain a prudent, pragmatic operating stance; strengthen internal governance; optimise resource allocation; improve product and service quality; and adjust business layout and product mix to capture niche opportunities, including a possible shift in travel demand toward closer destinations (IR26 cites UN Tourism's view that the Middle East conflict could cut 2026 international arrival growth by 1–2 points from an initial 3–4% forecast).
-
Deepening Cambodian capacity to capture Southeast Asian opportunities. Use the Cambodian factory as a core operational base for capacity synergy, cost management and supply-chain resilience; leverage labour-cost advantages, regional tariff concessions and logistics connectivity; further review and optimise the footprint in Cambodia and surrounding regions (AR25 Chairman's statement and Outlook; IR26).
-
Sustainability commitment. Embed ESG into strategy and operations; develop eco-friendly products, adopt energy-saving and carbon-reduction policies, source lower-impact raw materials (AR25; IR26).
-
Enduring client relationships through product and service quality. End-to-end supply-chain quality control; deeper collaboration with existing clients; expansion into emerging markets and new customers (AR25; IR26).
-
Prudent operations, capacity management and R&D optimisation. Increased focus on product development and technological upgrades; accelerate introduction of market-relevant products; flexible cross-regional capacity deployment (AR25; IR26).
For OS&E specifically, AR25 adds a goal of capturing Southeast Asian hotel-development activity and expanding strategic partnerships.
Initiatives in the last 24 months
| Initiative | Period | Description | Quantified target |
|---|---|---|---|
| Cambodia production reallocation | 2025–2026 | Customer-requested transfer of Health Care production from PRC to Cambodia; allocation of Hospitality orders to Cambodia | None disclosed |
| VIE structure renewal | 22 May 2024 | New Shareholders' Agreement and Power of Attorney make the Cambodian land-holding arrangement indefinite | — |
| Product portfolio adjustment in OS&E | 2025–2026 | Ongoing portfolio and quality-system optimisation | None disclosed |
| Eco-friendly product R&D | 2025–2026 | Development of ESG-compliant products and circular-economy practices | None disclosed |
| KPI assessment and annual commendation award schemes | Ongoing | Employee performance programmes | None disclosed |
Medium-term financial targets / guidance: Not publicly disclosed. The company provides no quantitative revenue, margin or earnings guidance; communication is limited to qualitative outlook language and Rule 13.09 profit warnings/alerts. The only quasi-policy target is the dividend policy, which has produced a payout ratio of ~50% for FY2023–FY2025 (AR24; AR25).
Products & Services
Hospitality Supplies Business
| Product line | Description / capabilities | Target customer | Launch / latest year | Pricing model | Source |
|---|---|---|---|---|---|
| Wet amenities | Shampoo, conditioner, shower gel, body lotion and similar liquid toiletries; in-house formulation and filling; blow-moulded bottles produced in-house | Hotels, resorts, airlines, cruise lines | Ongoing; launch year not disclosed | Not publicly disclosed (B2B contract / private label) | Vietnam Expo profile; WEB |
| Dry amenities and accessories | Guest-room accessories such as compact mirrors, bath items, umbrellas and similar consumables | Hotels | — | — | Morningstar business description |
| Acrylic hotel supplies and bath mats | Acrylic room accessories; bath mats | Hotels | — | — | Morningstar business description |
| Airline amenity kits | In-flight amenity kits and toiletries; sewing of handbags/pouches is an in-house capability | Airlines | — | — | WEB (production capabilities); AR25 (airline operators named as customers) |
| Private-label programmes | Customised formulations and packaging for hotel chains' own brands | Hotel chains | — | — | WEB; Malaysian JV profile |
| Licensed / distributed brands | Lanvin (Asia-Pacific rights from 2012), STORM (from Mar 2013), Aquascutum, Pasion, CULTI collections | Upscale and luxury hotels | 2012–2013 era; current status of each licence not publicly disclosed | — | WEB; Hotel Management Network profile |
| In-house luxury bath brands | Essence d'Orient; Rose Hotel Collection | Upscale hotels | c. 2013; current status not disclosed | — | Hotel Management Network profile |
| Sustainable / eco amenity ranges | Products designed with eco-friendly materials and ESG standards (e.g., reduced plastics, bulk formats); company also states support for abolition of animal testing | Hotels with sustainability programmes | Ongoing (2025–2026 emphasis) | — | AR25; WEB |
OS&E Business (trading)
| Product line | Contents | Target customer | Source |
|---|---|---|---|
| Lobby supplies | Signage, luggage carts, ashtray pillars, railing stands, trash bins, floor mats | Hotel openings and refurbishments | Simply Wall St business description |
| Cleaning supplies | Cleaning equipment, tools and agents | Hotels | Simply Wall St |
| Outdoor furniture | Leisure chairs, loungers, hammocks, swings, sun umbrellas | Resorts | Simply Wall St |
| Linens and bedding | Towels, bathrobes, tablecloths, bed sheets, blankets, pillows, work shoes and accessories | Hotels | Simply Wall St |
| Ceramic solutions | Porcelain sets, teacups, coffee utensils, glazed ceramics, Japanese and Korean ceramics, clay/stone pots, earthenware | Hotel F&B | Simply Wall St |
| Catering solutions | Buffet stoves and table-arrangement solutions, catering consumables, bakery supplies | Hotel F&B and banqueting | Simply Wall St |
| Kitchenware | Cutlery, pots, Chinese kitchen cookware and utensils | Hotel kitchens | Simply Wall St |
Health Care and Hygienic Products Business
| Product line | Description | Target customer | Source |
|---|---|---|---|
| Health-care and hygienic products | Personal hygiene and health-care consumables (specific SKUs not disclosed) | North American brand owners/retail customers | AR25; IR26 |
| Disposable infection-control products | Single-use infection-control items | North American and Hong Kong customers | AR25; IR26 |
Flagship offerings (named): Lanvin-licensed hotel amenities (Asia Pacific), Essence d'Orient, Rose Hotel Collection, Aquascutum hotel toiletries. The extent to which each remains active in 2026 is not publicly disclosed.
Financial Narrative
Income statement
Sources: AR25 five-year summary and MD&A (revenue, PBT, tax, profit, attributable profit, EPS, DPS, gross profit FY2024–25, operating profit FY2024–25); FY22R (gross profit and operating profit FY2021–22); TR (operating profit FY2023); SA (D&A). EBITDA is derived as company-reported operating profit plus depreciation and amortisation.
Revenue CAGR FY2021–FY2025: 11.7% (derived: (2,238.7/1,435.8)^(1/4) – 1).
Commentary on trends and drivers.
FY2021 trough: Revenue was depressed by the pandemic-era collapse in travel; gross margin fell to 18.8% and the company booked an operating loss with a HK$48.0M loss on sale of investments recognised in the cash-flow reconciliation (SA), producing a HK$93.5M attributable loss.
FY2022–FY2024 recovery: Management's own profit alerts attribute the recovery to the reopening of Western and Southeast Asian borders driving hospitality demand, a COVID-related spike in hygiene demand in Hong Kong in Q1 2022, and cost-control and high-margin-mix measures (FY2022 profit alert; PPA23). Revenue compounded at ~17% from FY2021 to FY2024, gross margin rose 6.3 percentage points to 25.1%, and attributable profit reached a decade-plus high of HK$143.2M.
FY2025 inflection: Revenue declined 3.1% and gross margin fell 3.5 points to 21.6%, cutting attributable profit by 29.7%. The decline was driven by Hospitality Supplies margin compression and the tariff-driven disruption in Health Care (AR25; 9M-25). Quarterly cadence shows the deterioration was progressive: Q1 2025 gross margin 23.9% (Q1-25), H1 22.7% (H1-25), 9M 22.3% (9M-25), full-year 21.6%.
FY2023 tax anomaly: The 33.6% effective tax rate in FY2023 (vs ~21–22% otherwise) depressed net profit conversion; the cause is not explained in the sources reviewed.
Half-year income statement (latest)
Source: IR26.
Analyst observation. The HK$19.8M decline in H1 2026 operating profit is almost fully explained by a HK$21.0M swing in foreign-exchange results (a HK$15.2M gain in H1 2025 turning into a HK$5.8M loss in H1 2026, booked within administrative expenses — IR26 Note 4) plus a HK$5.3M swing in receivable impairments. Underlying gross profit fell HK$12.7M, while distribution costs rose HK$5.3M on higher volumes. This means the headline 31.8% profit decline overstates the operating deterioration somewhat — but the gross-margin trend itself (19.1%, the lowest since FY2021) is the genuine concern. Note also that IR26 states the group has no foreign-currency hedging policy, so FX noise will persist.
Balance sheet
Sources: AR25 five-year summary (total assets, equity, liabilities); SA (component detail).
Bank and other borrowings (company definition, excluding leases and NCI loans): HK$26.1M at 31 Dec 2024; HK$11.6M at 31 Dec 2025; HK$6.3M at 30 Jun 2026. Undrawn banking facilities: HK$440.4M (31 Dec 2025) and HK$445.6M (30 Jun 2026). Gearing ratio "not applicable" (net cash) at every recent balance-sheet date (AR25; IR26).
30 June 2026 snapshot (IR26): total assets HK$1,983.9M; cash HK$345.5M (of which HK$113.2M held in PRC banks subject to exchange controls); pledged deposit HK$11.8M; trade and bills receivables HK$658.2M net (gross HK$750.1M less HK$91.9M provision); inventories HK$303.8M; equity attributable HK$1,414.9M; total equity HK$1,353.1M; total liabilities HK$630.7M.
Commentary. The balance sheet is conservatively financed and has de-levered steadily: total debt fell from HK$164.6M (FY2021) to HK$39.6M (FY2025), and net cash quadrupled. Two items warrant monitoring. First, receivables quality: the impairment provision equals 12.3% of gross receivables at 30 Jun 2026, and HK$99.2M (13.2%) is aged over 180 days, up from HK$90.4M at end-2025 (IR26 Note 8). Second, the persistent negative non-controlling interest (–HK$61.8M at 30 Jun 2026) indicates accumulated losses in non-wholly-owned subsidiaries, alongside HK$17.3M of loans from non-controlling interests; the specific subsidiaries are not identified in the sources reviewed.
Cash flow
Source: SA (S&P Global), cross-checked to TR for FY2021–FY2024.
Note: TR reports FY2022 FCF of HK$104.7M and FY2023 of HK$168.0M versus SA's HK$105.6M and HK$171.1M — minor definitional differences.
H1 2026 / TTM: SA reports trailing-twelve-month (to 30 Jun 2026) operating cash flow of only HK$18.8M and FCF of –HK$22.6M, implying a weak H1 2026 cash performance (consistent with cash falling HK$72.9M in the half to HK$345.5M despite only HK$29.4M in dividends — IR26).
Commentary. Cash generation is volatile and driven by working-capital swings — receivables absorbed HK$138.8M in FY2024 but released HK$109.6M in FY2025 (SA). Over FY2022–FY2025 the group generated cumulative FCF of ~HK$487M against cumulative dividends of ~HK$174M and debt reduction of ~HK$152M, funding the build of net cash. Capex is modest (1–3.5% of revenue); FY2024 capex (HK$77.8M) was the five-year peak.
Key ratios
Ratios are derived by this analyst from the tables above unless otherwise noted. ROE and ROA use year-end balances. ROIC = operating profit × (1 – effective tax rate) ÷ (total equity + total debt – cash). Interest coverage = operating profit ÷ cash interest paid (SA). CCC components use year-end balances and cost of sales = revenue – gross profit.
Notes: FY2021 net debt/EBITDA is mathematically positive only because both net cash and EBITDA were negative/positive in opposite directions — it is not meaningful. SA's own FY2025 ratios: ROE 7.65%, ROA 3.68%, ROIC 9.94% (different denominators). TR's interest coverage for FY2024 (182x) differs from the derived 60x due to definitional differences in finance cost. Payout ratios for FY2023–FY2025 are company-reported (AR24, AR25); FY2022 is derived (4.0/10.4).
Ratio commentary. Returns peaked in FY2024 (ROE 10.8%, derived ROIC 13.9%) and have since retreated toward high-single digits; on a TTM basis to June 2026 attributable profit of ~HK$84.5M (SA) implies ROE closer to 6%. Working-capital efficiency has improved structurally — the cash conversion cycle shortened by ~53 days from FY2021 to FY2025, driven by both lower DSO and leaner inventory. Liquidity is ample (current ratio 2.2x; net cash ~29% of total equity at end-2025).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains | Key geographies |
|---|---|---|
Hospitality Supplies Business | Manufacture and trading of hotel and airline guest amenities (wet amenities such as shampoo, shower gel, conditioner, body lotion; dry amenities and accessories; amenity kits) | PRC, Hong Kong, North America, Europe, Other Asia Pacific (Macau, Singapore, Japan, UAE, Philippines), Australia, Africa (Kenya, Morocco, Tanzania) |
OS&E Business | Trading of hotel operating supplies and equipment: lobby supplies, cleaning supplies, outdoor furniture, linens and bedding, ceramics, catering solutions, kitchenware | PRC (71–77%), other (Hong Kong, Macau, US) |
Health Care and Hygienic Products Business | Manufacture and supply of health-care and hygienic products and disposable infection-control products | North America (95–97%), Hong Kong, others |
Revenue by Segment
| Segment metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Hospitality Supplies revenue (HKD Mn) | 1,095.3 | 1,381.5 | 1,699.8 | 1,933.2 | 1,883.7 |
OS&E revenue (HKD Mn) | 156.4 | 149.5 | 193.3 | 210.4 | 228.5 |
Health Care and Hygienic revenue (HKD Mn) | 191.5 | 266.8 | 176.9 | 171.0 | 128.9 |
Inter-segment elimination (HKD Mn) | -7.4 | -4.7 | -2.7 | -3.3 | -2.3 |
Group revenue (HKD Mn) | 1,435.8 | 1,793.0 | 2,067.3 | 2,311.3 | 2,238.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment growth and mix (%)
| Segment growth and mix (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Hospitality Supplies YoY growth (%) | — | 26.1 | 23.0 | 13.7 | -2.6 |
OS&E YoY growth (%) | — | -4.4 | 29.3 | 8.8 | 8.6 |
Health Care YoY growth (%) | — | 39.4 | -33.7 | -3.4 | -24.6 |
Hospitality Supplies share of revenue (%) | 76.3 | 77.0 | 82.2 | 83.6 | 84.1 |
OS&E share of revenue (%) | 10.9 | 8.3 | 9.4 | 9.1 | 10.2 |
Health Care share of revenue (%) | 13.3 | 14.9 | 8.6 | 7.4 | 5.8 |
Segment gross profit
| Segment gross profit | FY2024 | FY2025 |
|---|---|---|
Hospitality Supplies gross profit (HKD Mn) | 477.0 | 391.4 |
OS&E gross profit (HKD Mn) | 51.6 | 53.4 |
Health Care gross profit (HKD Mn) | 51.3 | 39.9 |
Hospitality Supplies gross margin (%) | 24.7 | 20.8 |
OS&E gross margin (%) | 24.5 | 23.4 |
Health Care gross margin (%) | 30.0 | 31.0 |
Results by Segment and Segment Margins & Growth (%)
| Half-year segment metric | H1 2025 | H1 2026 |
|---|---|---|
Hospitality Supplies revenue, external (HKD Mn) | 877.6 | 914.3 |
OS&E revenue, external (HKD Mn) | 95.7 | 137.5 |
Health Care revenue, external (HKD Mn) | 55.3 | 106.4 |
Hospitality Supplies gross profit (HKD Mn) | 194.9 | 158.1 |
OS&E gross profit (HKD Mn) | 22.3 | 31.6 |
Health Care gross profit (HKD Mn) | 16.6 | 31.4 |
Hospitality Supplies gross margin (%) | 22.2 | 17.3 |
OS&E gross margin (%) | 23.3 | 23.0 |
Health Care gross margin (%) | 30.0 | 29.5 |
Hospitality Supplies segment PBT (HKD Mn) | 48.6 | 17.5 |
OS&E segment PBT (HKD Mn) | 5.7 | 9.0 |
Health Care segment PBT (HKD Mn) | 7.2 | 15.6 |
Unallocated / others PBT (HKD Mn) | -0.6 | -0.7 |
Segment assets (HKD Mn)
| Segment assets (HKD Mn) | 31 Dec 2025 | 30 Jun 2026 |
|---|---|---|
Hospitality Supplies total assets | 2,008.2 | 1,999.0 |
of which Cambodia | 396.5 | 421.4 |
OS&E total assets | 307.5 | 304.7 |
Health Care total assets | 69.3 | 95.3 |
Others | 38.3 | 38.4 |
Inter-segment elimination | -419.3 | -453.5 |
Group total assets | 2,004.0 | 1,983.9 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 1,435.8 | 1,793.0 | 2,067.3 | 2,311.3 | 2,238.7 |
Revenue growth (%) | 6.1 | 24.9 | 15.3 | 11.8 | -3.1 |
Gross profit (HKD Mn) | 269.6 | 424.8 | 501.7 | 579.9 | 484.7 |
Operating profit (HKD Mn) | -92.4 | 91.8 | 144.1 | 173.7 | 120.7 |
Depreciation and amortisation (HKD Mn) | 65.6 | 65.1 | 61.9 | 68.6 | 63.5 |
EBITDA, derived (HKD Mn) | -26.8 | 156.9 | 206.0 | 242.3 | 184.2 |
Profit before tax (HKD Mn) | -94.4 | 90.0 | 144.1 | 177.6 | 125.2 |
Income tax expense (HKD Mn) | 3.5 | 20.1 | 48.4 | 38.4 | 26.6 |
Profit for the year (HKD Mn) | -97.9 | 69.8 | 95.6 | 139.1 | 98.6 |
Profit attributable to owners (HKD Mn) | -93.5 | 75.5 | 104.2 | 143.2 | 100.7 |
Basic EPS (HK cents) | -12.8 | 10.4 | 14.4 | 19.8 | 13.9 |
Diluted EPS (HK cents) | -12.8 | 10.4 | 14.4 | 19.8 | 13.9 |
Dividend per share (HK cents) | 0 | 4.0 | 7.0 | 10.0 | 7.0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin metric (%)
| Margin metric (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 18.8 | 23.7 | 24.3 | 25.1 | 21.6 |
Operating margin (%) | -6.4 | 5.1 | 7.0 | 7.5 | 5.4 |
EBITDA margin, derived (%) | -1.9 | 8.8 | 10.0 | 10.5 | 8.2 |
Net margin, attributable (%) | -6.5 | 4.2 | 5.0 | 6.2 | 4.5 |
Effective tax rate (%) | -3.7 | 22.4 | 33.6 | 21.6 | 21.2 |
Income Statement and Margin Analysis (%) (Half-Yearly)
| Half-year metric | H1 2025 | H1 2026 |
|---|---|---|
Revenue (HKD Mn) | 1,028.6 | 1,158.2 |
Cost of sales (HKD Mn) | 794.8 | 937.1 |
Gross profit (HKD Mn) | 233.8 | 221.1 |
Gross margin (%) | 22.7 | 19.1 |
Other income (HKD Mn) | 3.6 | 4.5 |
Distribution costs (HKD Mn) | 109.3 | 114.7 |
Administrative expenses (HKD Mn) | 69.7 | 67.1 |
Net impairment (losses)/reversals on financial assets (HKD Mn) | 1.4 | -3.9 |
Operating profit (HKD Mn) | 59.7 | 40.0 |
Net finance income (HKD Mn) | 1.0 | 1.5 |
Profit before tax (HKD Mn) | 61.3 | 42.0 |
Income tax (HKD Mn) | 11.1 | 8.3 |
Profit attributable to owners (HKD Mn) | 50.9 | 34.7 |
Basic EPS (HK cents) | 7.0 | 4.8 |
Interim DPS (HK cents) | 3.0 | 2.5 |
Net exchange (loss)/gain within expenses (HKD Mn) | 15.2 | -5.8 |
Employee benefit expenses (HKD Mn) | 263.0 | 275.9 |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 1,738.7 | 1,749.5 | 1,965.2 | 1,995.3 | 2,004.0 |
Current assets (HKD Mn) | 1,144.7 | 1,204.3 | 1,406.9 | 1,441.3 | 1,456.7 |
Cash and cash equivalents (HKD Mn) | 251.2 | 305.4 | 375.1 | 328.6 | 418.4 |
Trade and other receivables (HKD Mn) | 557.4 | 575.0 | 622.7 | 741.1 | 673.5 |
Inventories (HKD Mn) | 266.3 | 260.2 | 329.1 | 307.9 | 290.3 |
Property, plant and equipment incl. ROU (HKD Mn) | 551.4 | 507.1 | 490.3 | 490.4 | 461.7 |
Goodwill and intangibles (HKD Mn) | 5.8 | 5.9 | 5.7 | 5.7 | 5.9 |
Short-term debt incl. loans from NCI (HKD Mn) | 156.0 | 126.0 | 64.3 | 41.3 | 27.0 |
Long-term debt (HKD Mn) | 2.7 | 2.2 | 2.2 | 1.8 | 1.6 |
Lease liabilities (HKD Mn) | 5.9 | 9.0 | 8.3 | 3.0 | 11.0 |
Total debt incl. leases (HKD Mn) | 164.6 | 137.2 | 74.8 | 46.1 | 39.6 |
Net cash (HKD Mn) | 88.1 | 169.8 | 302.0 | 285.0 | 380.3 |
Current liabilities (HKD Mn) | 621.7 | 596.4 | 748.6 | 714.1 | 665.6 |
Total liabilities (HKD Mn) | 644.3 | 618.0 | 772.0 | 732.0 | 690.1 |
Equity attributable to owners (HKD Mn) | 1,141.0 | 1,181.0 | 1,251.0 | 1,323.0 | 1,375.1 |
Non-controlling interests (HKD Mn) | -46.2 | -49.7 | -57.5 | -60.0 | -61.2 |
Total equity (HKD Mn) | 1,094.4 | 1,131.5 | 1,193.2 | 1,263.3 | 1,313.9 |
Working capital (HKD Mn) | 523.0 | 608.0 | 658.3 | 727.1 | 791.1 |
Book value per share (HKD) | 1.55 | 1.61 | 1.70 | 1.80 | 1.87 |
Cash Flow and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) | -98.7 | 129.8 | 228.7 | 113.1 | 205.8 |
Change in working capital (HKD Mn) | -112.5 | -37.7 | 50.5 | -96.1 | 73.4 |
Capital expenditure (HKD Mn) | -44.3 | -24.2 | -57.6 | -77.8 | -30.4 |
Free cash flow (HKD Mn) | -143.0 | 105.6 | 171.1 | 35.3 | 175.4 |
FCF margin (%) | -10.0 | 5.9 | 8.3 | 1.5 | 7.8 |
Dividends paid (HKD Mn) | -10.9 | -7.2 | -36.2 | -57.9 | -72.3 |
Share buybacks (HKD Mn) | 0 | -2.2 | 0 | 0 | 0 |
Net debt repaid (HKD Mn) | 14.6 | -36.0 | -67.3 | -28.6 | -20.1 |
Cash income tax paid (HKD Mn) | 33.1 | -4.0 | 38.8 | 45.6 | 53.6 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, attributable (%) | -8.2 | 6.4 | 8.3 | 10.8 | 7.3 |
ROA (%) | -5.6 | 4.0 | 4.9 | 7.0 | 4.9 |
ROIC, derived (%) | -9.2 | 7.4 | 10.7 | 13.9 | 10.2 |
Current ratio (x) | 1.84 | 2.02 | 1.88 | 2.02 | 2.19 |
Debt to equity (x) | 0.15 | 0.12 | 0.06 | 0.04 | 0.03 |
Net debt to EBITDA (x, negative = net cash) | 3.29 | -1.08 | -1.47 | -1.18 | -2.06 |
Interest coverage (x) | -38.0 | 19.5 | 23.1 | 60.1 | 91.4 |
Asset turnover (x) | 0.83 | 1.02 | 1.05 | 1.16 | 1.12 |
Days sales outstanding | 135.0 | 114.4 | 108.5 | 115.6 | 105.4 |
Days inventory outstanding | 83.3 | 69.4 | 76.7 | 64.9 | 60.4 |
Days payables outstanding | 55.8 | 44.9 | 65.9 | 55.6 | 56.0 |
Cash conversion cycle (days) | 162.5 | 138.9 | 119.3 | 124.9 | 109.8 |
Dividend payout ratio (%) | 0 | 38.5 | 48.6 | 50.5 | 50.4 |
Revenue by Region
| Region (group revenue, HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Mainland China (Hospitality + OS&E) | 635.5 | 457.6 | 691.1 | 686.1 | 635.1 |
Hong Kong (Hospitality + Health Care) | 202.9 | 254.1 | 187.6 | 296.5 | 366.3 |
North America (Hospitality + Health Care) | 264.8 | 338.1 | 413.3 | 485.4 | 401.0 |
Europe (Hospitality) | 97.3 | 251.0 | 262.1 | 315.9 | 297.8 |
Other Asia Pacific (Hospitality) | 144.5 | 262.2 | 357.0 | 375.7 | 365.9 |
Australia (Hospitality) | 30.4 | 151.0 | 91.4 | 90.1 | 101.0 |
Other / unallocated | 60.5 | 79.1 | 64.8 | 61.5 | 71.7 |
Total | 1,435.8 | 1,793.0 | 2,067.3 | 2,311.3 | 2,238.7 |
Regional growth (YoY %)
| Regional growth (YoY %) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Mainland China | 51.0 | -0.7 | -7.4 |
Hong Kong | -26.2 | 58.0 | 23.5 |
North America | 22.3 | 17.4 | -17.4 |
Europe | 4.4 | 20.5 | -5.7 |
Other Asia Pacific | 36.2 | 5.2 | -2.6 |
Australia | -39.5 | -1.4 | 12.1 |
Revenue by Region (FY2024–FY2025)
| Hospitality Supplies region (HKD Mn) | FY2024 | FY2025 |
|---|---|---|
PRC | 528.0 | 470.9 |
Hong Kong | 294.4 | 363.2 |
North America | 323.0 | 278.1 |
Europe | 315.9 | 297.8 |
Other Asia Pacific | 375.7 | 365.9 |
Australia | 90.1 | 101.0 |
Hospitality Supplies region share (%)
| Hospitality Supplies region share (%) | FY2024 | FY2025 |
|---|---|---|
PRC | 27.3 | 25.0 |
Hong Kong | 15.2 | 19.3 |
North America | 16.7 | 14.8 |
Europe | 16.4 | 15.8 |
Other Asia Pacific | 19.5 | 19.4 |
Australia | 4.7 | 5.4 |
Revenue by Region (Half-Yearly)
| Hospitality Supplies region, half-year (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
PRC | 208.0 | 232.7 |
Hong Kong | 138.4 | 194.5 |
North America | 158.2 | 123.7 |
Europe | 147.6 | 134.2 |
Other Asia Pacific | 172.5 | 176.9 |
Australia | 51.3 | 50.6 |
Revenue by Region by OS&E and Health Care Regions
| OS&E and Health Care regions (HKD Mn) | FY2024 | FY2025 |
|---|---|---|
OS&E — PRC | 155.3 | 162.7 |
OS&E — other markets | 55.1 | 65.8 |
Health Care — North America | 162.4 | 122.9 |
Health Care — Hong Kong | 1.8 | 2.3 |
Health Care — other markets | 6.6 | 3.5 |
Revenue by Region (H1 2025–H1 2026)
| OS&E and Health Care regions, half-year (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
OS&E — PRC | 65.2 | 105.7 |
OS&E — other markets | 30.5 | 31.8 |
Health Care — North America | 52.4 | 102.8 |
Health Care — Hong Kong | 1.0 | 1.7 |
Health Care — other markets | 1.9 | 1.9 |
Capital Markets
| Item | Value | Date / basis | Source |
|---|---|---|---|
Share price | HK$0.725 | 9 Oct 2026 | SA |
Share price | HK$0.77 | 17 Jul 2026 and 31 Jul 2026 | SA |
52-week price change | -10.47% | to 17 Jul 2026 | SA |
50-day / 200-day moving average | HK$0.79 / HK$0.89 | 17 Jul 2026 | SA |
Beta (5Y) | 0.45 | Jul 2026 | SA |
Market capitalisation | ≈HK$532M | 9 Oct 2026, derived | derived |
Enterprise value | ≈HK$219M (market cap + HK$32.3M debt incl. leases/NCI loans – HK$345.5M cash at 30 Jun 2026) | derived | derived |
P/E (TTM attributable profit HK$84.5M) | ≈6.3x | derived | derived from SA |
P/E (FY2025) | ≈5.3x | derived | derived |
EV/EBITDA (TTM, ≈HK$160M) | ≈1.4x | derived | derived |
EV/Sales (TTM revenue HK$2,368M) | ≈0.09x | derived | derived |
P/B (equity attributable HK$1,414.9M) | ≈0.38x | 30 Jun 2026, derived | derived |
Dividend yield (TTM DPS HK$0.065) | ≈9.0% | Oct 2026 | SA |
Average daily volume (20 days) | ~201,600 shares | Jul 2026 | SA |
Altman Z-score / Piotroski F-score | 2.81 / 6 | Jul 2026 | SA |
Dividend metric
| Dividend metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total DPS (HK cents) | 0 | 4.0 | 7.0 | 10.0 | 7.0 |
Payout ratio (%) | 0 | 38.5 | 48.6 | 50.5 | 50.4 |
Dividends paid in cash (HKD Mn) | 10.9 | 7.2 | 36.2 | 57.9 | 72.3 |
Analyst Conclusions
Management guidance
No quantitative guidance. Management describes a cautiously optimistic stance (AR25 Chairman's statement), anchored on continuous innovation and sustainability as dual growth drivers, flexible capacity deployment in Cambodia, and prudent financial management (AR25; IR26). Consensus growth expectations: none available.
Bull case (grounded in data above)
-
Margin trough plus volume recovery. H1 2026 revenue grew 12.6% with all three segments growing; if gross margin merely recovers to its FY2025 level of 21.6% from 19.1%, the improvement on a ~HK$2.3–2.4bn revenue base would be worth roughly HK$55–60M of gross profit annually — more than half of FY2025 attributable profit.
-
Cambodia as a structural winner. Health Care revenue nearly doubled and segment PBT more than doubled in H1 2026 once Cambodian capacity ramped; US customers' diversification away from China supports further allocation to the plant.
-
Extreme valuation cushion. At ≈0.38x book, ≈1.4x EV/EBITDA and a ~9% dividend yield, with net cash covering roughly 60% of market capitalisation, the market is pricing in sustained decline; the FX loss in H1 2026 (HK$5.8M) is non-recurring by nature.
Bear case
-
Structural margin compression in the core. Hospitality gross margin has fallen from 24.7% (FY2024) to 17.3% (H1 2026); management attributes this to competition and costs, suggesting pricing power is weak and the decline may not be cyclical.
-
Deteriorating cash conversion. TTM operating cash flow to June 2026 was only HK$18.8M and TTM FCF negative (SA); cash fell by HK$72.9M in H1 2026, and receivables over 180 days are rising.
-
Governance and capital-allocation discount is likely to persist. A family-controlled board without a CEO, no buybacks since 2022 despite a deep discount to book, and an expired share-award scheme with no grants ever made give minority holders limited catalysts.
Key catalysts and monitorables (next 12 months)
| Monitorable | Why it matters | Timing |
|---|---|---|
| Voluntary 9M 2026 business update | Tests whether H2 margins stabilise; company issued 9M updates in Nov 2025 | ~Nov 2026 |
| FY2026 profit warning / alert | Rule 13.09 announcements have preceded each of the last two results | ~Mar 2027 |
| FY2026 annual results and final dividend | Payout policy and margin trajectory | ~late Mar 2027 |
| Hospitality gross margin | Core driver of earnings | Each reporting period |
| Oil, resin and freight costs | IR26 links margin pressure to oil prices | Continuous |
| US tariff decisions on PRC and Cambodian origins | Drives Health Care and North America Hospitality | Continuous |
| China hotel openings and pipeline | OS&E demand | Quarterly Lodging Econometrics data |
| Receivable ageing and impairments | Credit quality | Each reporting period |
| Share-award scheme renewal or buyback activity | Capital-allocation signal | AGM ~May 2027 |
| Webb holdings changes (16.33%) | Potential shareholder activism or exit | Disclosure-of-interest filings |
Analyst verdict
Ming Fai International is a financially sound but operationally pressured small-cap manufacturer whose share price reflects a market that has largely stopped believing in its earnings power. The facts are stark in both directions. On one side, the group carries net cash of over HK$300 million, minimal borrowings, HK$445 million of undrawn facilities, and an equity base of HK$1.41 billion against a market capitalisation of roughly HK$530 million. It has paid out about half of its profits for three consecutive years, and its H1 2026 top line grew double-digits across every segment, with Cambodia emerging as a genuine strategic asset for tariff-sensitive North American customers.
On the other side, the core Hospitality Supplies franchise — 79–84% of revenue — is losing margin at an alarming pace: from 24.7% in FY2024 to 17.3% in H1 2026, collapsing segment profit by nearly two-thirds year-on-year. Management's explanations (cost inflation, competition, external volatility) are plausible but also imply weak pricing power. Cash generation weakened markedly in the first half of 2026, receivable ageing is drifting upward, and the absence of hedging leaves earnings exposed to RMB swings.
Governance offers little catalyst: a founder-controlled board with family representation, no CEO, no buybacks despite trading at under 0.4x book, and no disclosed medium-term targets. The 16.33% stake held by Webb-linked entities is the most interesting latent governance variable.
Our assessment is that the stock is statistically cheap and balance-sheet protected, but a re-rating requires evidence that Hospitality margins have bottomed — something the next 9M update and FY2026 results will test. Until then, the investment case is essentially a high-yield, asset-backed holding with meaningful dividend-cut risk (DPS has already fallen from 10.0 to 7.0 cents, and the interim from 3.0 to 2.5 cents). Verdict: value with a margin-recovery option; monitor, rather than chase.
All figures are from public company filings and named third-party data providers as cited. "Derived" figures are analyst calculations from disclosed data.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Age (AR25) | Board tenure | Prior roles / responsibilities | Education |
|---|---|---|---|---|---|
CHING Chi Fai | Chairman, Executive Director; chairs Nomination, Executive and Investment Committees; member Remuneration Committee | 64 | Since 2007 (18 years) | Founder; responsible for sales & marketing, production and overall corporate direction; 30+ years in hospitality supplies | — |
CHING Chi Keung | Executive Director; member Executive Committee | 61 | Since 2007 | Joined with founders; human resources and administration; brother of Chairman | — |
LIU Zigang | Executive Director; member Executive Committee | 60 | Since 2007 | Joined May 1995; oversees Greater China sales | MBA, Centenary College of New Jersey (2011); diploma, Shenzhen University; Tsinghua University international business management course |
CHING Tsun Wah | Executive Director; Business Development Director; member Executive Committee | 44 | Since 2014 (11 years) | Joined 2006 in production; oversees Southeast Asia and overseas sales; son of Chairman; Cambodian citizen; holds 51% of Cambodian land-holding company under VIE | Marketing administration, Seneca College, Toronto (2003) |
KEUNG Kwok Hung | Executive Director; CFO; Company Secretary; member Executive and Investment Committees | 53 | Since 2014 | Joined Jul 2010; 30+ years accounting/finance | BA Accountancy, Hong Kong Polytechnic University; FCPA (HKICPA), FCCA |
CHAN Yim Ching | Non-Executive Director; member Nomination Committee | 58 | NED since 2015; ED 2007–2015 | Joined 1995; export sales | — |
HUNG Kam Hung Allan | Independent NED; chairs Remuneration Committee | 71 | Since 2007 (18 years) | Former deputy MD/ED of Top Glory International; hotel development consultant since 2005 | — |
SUN Eric Yung Tson | Independent NED | 49 | Since 2016 (9 years) | MD of Kin Hip Metal & Plastic Factory and KINOX Trading since 2006; president, HK Plastics Manufacturers Association; chairman, HK Exporters' Association | B.Com, University of New South Wales (2000) |
KWONG Tony Wan Kit | Independent NED; chairs Audit Committee; member Investment Committee | 48 | Since 2021 (4 years) | CFO of Top Form International (HKEX-listed); former roles at Wise Ally, Defond, Valuetronics | MBA, Anglia Ruskin University; BBA Accountancy, City University of Hong Kong; FCPA, FCCA |
“—” = not publicly disclosed.
Directors' Remuneration
| Attribute | Detail |
|---|---|
Board size | 9 (5 ED, 1 NED, 3 INED) |
Independence | 33% independent (3 of 9) — meets the Listing Rules minimum of one-third |
Gender | 1 female (11%); board target is to maintain at least one female director |
Age profile | 1 director aged 40–49... (AR25 chart: 1 in 40–49, 1 in 50–59, 7 aged 60 or above per board-diversity chart; note bios list two directors aged 48–49, so chart groupings appear to be by different cut-offs — discrepancy noted) |
Chair/CEO | No CEO; Chairman is the founder and controlling shareholder |
Family relationships | Chairman, his brother (ED) and his son (ED) all sit on the board |
Audit Committee | Kwong (Chair), Hung, Sun — all INEDs |
Remuneration Committee | Hung (Chair), Ching Chi Fai, Sun, Kwong |
Nomination Committee | Ching Chi Fai (Chair), Chan Yim Ching, Hung, Sun, Kwong |
Executive Committee | All five EDs, chaired by Ching Chi Fai |
Investment Committee | Ching Chi Fai (Chair), Keung, Kwong |
Terms | EDs: 3-year service contracts; NED/INEDs: 1-year letters of appointment; all subject to rotation |
Major Shareholders
| Holder | Shares | % of issued | Nature |
|---|---|---|---|
CHING Chi Fai (incl. Prosper Well International 165,166,600; 30.77% attribution of Targetwise's 32,499,600; personal 23,690,000) | 221,356,200 | 30.15 | Controlling shareholder (spouse LO Kit Ling deemed interested in same shares) |
Prosper Well International Limited (wholly owned by Ching Chi Fai) | 165,166,600 | 22.49 | Included above |
David Michael WEBB and Karen Anne WEBB (jointly, via Preferable Situation Assets and Member One) | 119,920,000 | 16.33 | Substantial shareholder |
Preferable Situation Assets Limited | 69,987,700 | 9.53 | Webb vehicle |
Member One Limited | 49,932,300 | 6.80 | Webb vehicle |
CHING Chi Keung (incl. Targetwise Trading 32,499,600) | 36,499,600 | 4.97 | Director |
CHAN Yim Ching (via Targetwise Trading) | 32,499,600 | 4.43 | Director (overlaps with Targetwise above) |
LIU Zigang (incl. Favour Power 20,057,200) | 24,057,200 | 3.28 | Director |
CHING Tsun Wah (incl. spouse 775,000) | 4,509,000 | 0.61 | Director |
HUNG Kam Hung Allan | 600,000 | 0.08 | INED |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | HQ | Ownership | Positioning vs Ming Fai |
|---|---|---|---|---|
ADA Cosmetics International | Hotel amenities (licensed luxury brands) | Germany | Private | Strong in European luxury licensed amenities; competes in Europe and Asia |
Guest Supply | Hotel amenities and guest-room supplies | United States | Division of Sysco | Scale distributor in North America with procurement leverage |
Gilchrist & Soames | Luxury hotel amenities | United States | Private | Upscale North American brand-led amenities |
Marietta Corporation | Private-label hotel amenities manufacturing | United States | Private | North American contract manufacturer; direct rival in private label |
Hunter Amenities | Hotel amenities | Canada | Private | North American amenities supplier |
Mainland Chinese amenity manufacturers (Yangzhou/Guangdong clusters) | Hotel amenities, dry goods | PRC | Mostly private | Low-cost competition; primary source of the "intensified competition" management cites |
Regional OS&E specialists in China and Southeast Asia | OS&E for hotel openings | PRC / SE Asia | Private | Project-based competition for hotel openings |
Hotel chains' in-house/global procurement programmes | Amenities, OS&E | Global | Divisions of hotel groups | Monopsony buyers that can tender globally |
Health-care OEM manufacturers in Southeast Asia (Vietnam, Malaysia, Thailand, Indonesia) | Health care and hygienic contract manufacturing | SE Asia | Mixed | Alternative "China+1" origins for US customers |
PRC hygiene/disposable producers | Infection-control disposables | PRC | Mixed | Tariff-disadvantaged into US but price-competitive elsewhere |
Competitor Detail
| Benchmark metric | Ming Fai FY2025 |
|---|---|
Revenue | HK$2,238.7M |
Revenue growth | -3.1% |
Gross margin | 21.6% |
Operating margin | 5.4% |



